[Federal Register Volume 71, Number 137 (Tuesday, July 18, 2006)]
[Notices]
[Pages 40723-40724]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 06-6276]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration


Request for Nominations for Voting Members on a Public Advisory 
Committee; Pediatric Advisory Committee

AGENCY:  Food and Drug Administration, HHS.

ACTION:  Notice.

-----------------------------------------------------------------------

SUMMARY:  The Food and Drug Administration (FDA) is requesting 
nominations for voting members to serve on the Pediatric Advisory 
Committee in the Office of the Commissioner. Nominations will be 
accepted for vacancies that have occurred on or before June 30, 2006.
    FDA has special interest in ensuring that women, minority groups, 
and individuals with disabilities are adequately represented on 
advisory committees and, therefore, encourages nominations of qualified 
candidates from these groups.

DATES:  No cutoff date is established for the receipt of nominations. 
However, nominations received on or before July 28, 2006, will be given 
first consideration for membership on the Pediatric Advisory Committee.

ADDRESSES:  All nominations for membership should be sent to Jan 
Johannessen (see FOR FURTHER INFORMATION CONTACT).

FOR FURTHER INFORMATION CONTACT:  Jan N. Johannessen, Office of Science 
and Health Coordination (HF-33), Food and Drug Administration, 5600 
Fishers Lane, Rockville, MD 20857, 301-827-6687, FAX 301-827-3042, e-
mail: [email protected].

SUPPLEMENTARY INFORMATION: FDA is requesting nominations for voting 
members on the Pediatric Advisory Committee. There are currently six 
vacancies on this committee. These vacancies need to be filled as soon 
as possible.

I. Function of the Pediatric Advisory Committee

    The committee advises the Commissioner of Food and Drugs on 
pediatric therapeutics, pediatric research, and other matters involving 
pediatrics for which FDA has regulatory responsibility. The Committee 
also advises and makes recommendations to the Secretary of Health and 
Human Services under 21 CFR 50.54 for products regulated by FDA and 45 
CFR 46.407 on research involving children as

[[Page 40724]]

subjects that is conducted or supported by the Department of Health and 
Human Services and involves a product regulated by FDA.

II. Qualifications

    Persons nominated for membership on the committees shall have 
scientific expertise in one or more of the following areas: Pediatric 
research, pediatric subspecialties, pediatric therapeutics, statistics, 
and/or biomedical ethics. There is a particular need for clinical and/
or scientific expertise in pediatric neurology, adolescent medicine or 
statistics. The term of office is up to 4 years, depending on the 
appointment date.

III. Nomination Procedures

    Any interested person may nominate one or more qualified persons 
for membership on the Pediatric Advisory Committee. Self-nominations 
are also accepted. Nominations shall include the name of the committee, 
a complete curriculum vitae of each nominee, current business address 
and telephone number, and shall state that the nominee is aware of the 
nomination, is willing to serve as a member, and appears to have no 
conflict of interest that would preclude membership. FDA will ask the 
potential candidates to provide detailed information concerning such 
matters as financial holdings, employment, and research grants and/or 
contracts to permit evaluation of possible sources of conflict of 
interest.
    This notice is issued under the Federal Advisory Committee Act (5 
U.S.C. app. 2) and 21 CFR part 14, relating to advisory committees.

    Dated: July 10, 2006.
Randall W. Lutter,
Associate Commissioner for Policy and Planning.
[FR Doc. 06-6276 Filed 7-17-06; 8:45 am]
BILLING CODE 4160-01-S